Pricing Log in Create free account

Ardelyx, Inc. (ARDX) vs Janux Therapeutics, Inc. (JANX)

Ardelyx, Inc. and Janux Therapeutics, Inc. are both Biotechnology companies. Ardelyx, Inc. and Janux Therapeutics, Inc. are of similar size ($786.8M and $758.1M). Janux Therapeutics, Inc. grew revenue faster over the last twelve months: 214.4% against 17.6%. Ardelyx, Inc. has the higher net margin (−11.9% vs −300.0%) and the lower return on invested capital (−17.2% vs 0.00%). Across the 17 metrics below, Janux Therapeutics, Inc. leads on 10 and Ardelyx, Inc. on 7.

Valuation

Metric ARDX JANX Biotechnology median
P/E n/m n/m 11.58
P/S 1.68 23.60 9.61
P/B 4.79 0.86 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m 1.07 0.72
EV/Sales 1.66 (4.81) 9.43
Earnings yield (7.10%) (12.77%) (32.28%)
Free cash flow yield (2.03%) (6.90%) (22.27%)

Profitability

Metric ARDX JANX Biotechnology median
Gross margin 94.46% 100.00% 68.81%
Operating margin (7.71%) (419.24%) 0.00%
Net margin (11.85%) (299.95%) 0.00%
Free cash flow margin (3.41%) (162.70%) 0.00%
Return on equity (34.85%) (10.58%) (50.30%)
Return on assets (10.33%) (9.94%) (45.47%)
Return on invested capital (17.21%) 0.00% 0.00%

Growth

Metric ARDX JANX Biotechnology median
Revenue growth (TTM) 17.57% 214.40% 6.78%
EPS growth (last fiscal year) (52.94%) (42.97%) 29.88%
Revenue growth, 5-year CAGR 121.90% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARDX JANX Biotechnology median
Debt to equity 1.54 0.00 0.00
Current ratio 3.45 17.69 4.74
Net debt to EBITDA 1.63 5.58 1.01

Dividend

Metric ARDX JANX Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric ARDX JANX Biotechnology median
Market cap 786.79m 758.06m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack